IL-13 x TSLP

Asset

Bispecific antibody targeting IL-13 and TSLP for Type 2 inflammatory airway disease control.

Stage
Phase 1
Modality
Antibody
Target
TSLP
1
Indication
0
Trials
1
Developer

Indications

1

In the full profile

  • Targets and what it contains3
  • Owner and partners1
  • Evidence for its targets3
  • Competitors3
  • Aging relevance1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets